Psychosomatic Illnesses Secondary to Drug Treatment

  • L. K. Oyewumi


The influence of the Mind (psyche) on the dysfunction and disease in the body (soma) has been recognized for many years, dating from the era of the Greek and Roman civilizations. The observation that emotions had profound effects on the body had been dealt with by many scientific thinkers such as Freud, Hughlings-Jackson, Sherrington, Franz Alexander, Cannon, and Hans Selye to mention a few. This led to the concept of psychosomatic medicine which represents one of the major breakthroughs of the twentieth century medicine. It is now firmly established that there are reciprocal relationships among sociological, psychological and biological factors in maintaining health and in influencing the onset and course of diseases. Many practitioners believe that emotions are involved in every stage of illness, even though the importance of the emotional factors varies from one stage of the illness to the other. Swenson 1981, contends that “just as no man is an island unto himself, so no soma or medical illness can be identified as existing completely independent of the psyche”. Most physicians today advocate the psychosomatic or holistic approach to medical practice. This obviously developed from the clinical observations and humane concern for the sick individual.


Eating Disorder Sexual Dysfunction Premature Ejaculation Hypersexual Behavior Night Eating Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1).
    American Psychiatric Association Diagnostic Statistical Manual II, 1968.Google Scholar
  2. 2).
    American Psychiatric Association Diagnostic Statistical Manual III, 1980.Google Scholar
  3. 3).
    Azarnoff, D. L., 1970. Application of metabolic data to the evaluation of drugs. JAMA 211: 1691.PubMedCrossRefGoogle Scholar
  4. 4).
    Ayd, F. J., 1959. Drug-induced depressions: Fact or Fallacy. New York J. Med. 58: 354–356.Google Scholar
  5. 5).
    Blair, J. H., Simpson, G. M. 1966. Effect of antipsychotic drugs on reproductive functions. Dis. Nerv. Syst. 27: 645–647..Google Scholar
  6. 6).
    Boston Collaborative Drug Surveillance Program. 1971. Psychiatric Side Effects of Non-psychiatric Drugs. Sem: Psychiat. 3: 406.Google Scholar
  7. 7).
    Caranosos, G. J., Stewart, R. G., Cliff, L. E.: 1974. Drug-induced illnesses leading to hospitalization. JAMA 228: 713–717.CrossRefGoogle Scholar
  8. 8).
    Charney, D. S., Kales, A., Soldatos, C. R., and Nelson, J. C.: Nov. 1979. Somnalistic-like episodes secondary to combined lithium - neuroleptic treatment. Brit. J. Psychiatr. 135: 418–424.Google Scholar
  9. 9).
    Chouinard, G., Annable, L., Korpsky, M.: 1978. Apothiazine in schizophrenia. J. Clin. Pharmacol. 18: 148–154.Google Scholar
  10. 10).
    Cicero, T. J., Bell, R. D., Wiest, W. G. et al. 1975. Functions of the male sex organs in Heroin and Methedone users. N. Engl. J. Med. 292: 882–887.Google Scholar
  11. 11).
    Cooper-Smart, J. D., Rodham, R.: 1973. A technique for surveying side-effects of tricyclic drugs with reference to reported sexual effects. J. Int. Med. Res. 1: 473–476.Google Scholar
  12. 12).
    Cousins, N.: 1970. Can doctors cause disease? Saturday Review (Aug 22 ), 30–32.Google Scholar
  13. 13).
    Engel, G. L.: 1977. The need for a new medical model: A challenge for biomedicine. Science 196: 129–134.Google Scholar
  14. 14).
    Freyhan, F. A.: 1961. Loss of ejaculation during Mellaril treatment. Am. J. Psychiatry 118: 171–172.Google Scholar
  15. 15).
    Goodwin, F. K.: 1972. Behavioral effects of L-Doga in Man - Chapter in: Psychiatric Complications of Medical Drugs: Ed. R. I. Shader, Raven Press Books Ltd.Google Scholar
  16. 16).
    Hughes, J. M.: 1964. Failure to ejaculate with chlordiazepoxide. Am. J. Psychiatry, 121: 610–611.Google Scholar
  17. 17).
    Illich, I.: 1975. Medical Nervesis: The Exploration of Health. McClelland and Stewart in Association with Marion Boyars Publishers Ltd., LondonGoogle Scholar
  18. 18).
    Kotin, J., Wilbert, D. E., Verburg, D., Soldinger, S. M.: 1976. Thioridazine and sexual dysfunction. Am. J. Psychiatry. 133 /1: 82–85.PubMedGoogle Scholar
  19. 19).
    Lacoursïere, Spohn, H. E., Thomson, K.: March/April 1976. Medical effects of abrupt neuroleptic withdrawal. Compr. Psychiatry: 17/2.Google Scholar
  20. 20).
    Liarantonakis, E., Kotroutsos, E., Zacharakopoulou, E.: 1977. Obesity related to the use of psychoactive drugs. Behay. Neuropsychiatry, *: 36–38.Google Scholar
  21. 21).
    Lipowski, Z. J.: 1975. Psychiatry of somatic disease. Epidemiology, pathogenesis, classification. Compr. Psychiatry, 16: 2: 105–124.PubMedCrossRefGoogle Scholar
  22. 22).
    Marriott, P., Pansa, M., Hiep, A.: 1981. Depot Fluphenazine maintenance treatment and associated weight changes. Comprehensive Psychiatry, Vol. 22, No. 3, 320–325.PubMedCrossRefGoogle Scholar
  23. 23).
    Melman, K. L.: 1971. Preventable drug reactions - Causes and cures. N. Engl. J. Med. 284: 1361–1368.Google Scholar
  24. 24).
    Osborne, M.P.: 1974. Penile Parkinsonism: Postgraduate Medical Journal, 50: 523–524.PubMedGoogle Scholar
  25. 25).
    Prien, R. F.: 1973. Chemotherapy in chronic organis brain syndrome. A review of the literature: Psychopharmacol. Bull. 9 /4: 5–20.Google Scholar
  26. 26).
    Ryan, H. F., Merill, F. B., Scott, C. E. et al. 1968. Increase in suicidal thoughts and tendencies: Association with`dïazepam therapy. JAMA, 203: 1137–1139.Google Scholar
  27. 27).
    Sarwer-Foner, G. J.: 1960. Recognition and management of drug-induced extrapyramidal reactions and paradoxical reactions in psychiatry. Can. Med. Assoc. J. 83: 312–318.Google Scholar
  28. 28).
    Segraves, R. T.: 1977. Pharmacological agents causing sexual dysfunctions. J. of Sex and Marital Therapy, 3 /3.Google Scholar
  29. 29).
    Selikoff, I. J., Robitzek, E. H., Ornstein, C. G.: 1952. Toxicity of hydrazine derivatives of isonicotinic acid in the chemotherapy of human tuberculosis. Quart. Bull. Sea View Hosp. 13: 17–26.Google Scholar
  30. 30).
    Singh, J.: 1963. Therapeutic use of thioridazine in premature ejaculation. Am. J. Psychiatry, 119: 891.Google Scholar
  31. 31).
    Story, H. L.: 1974. Sexual dysfunction resulting from drug side effects. J. Sex Res. 10: 132–149.PubMedCrossRefGoogle Scholar
  32. 32).
    Swanson, D. A.: Oct 1975. Benzodiazepines in psychiatry. S. A. Med. J. 1829–1834: 18Google Scholar
  33. 33).
    Swenson, W. J.: May 1981. Psychological correlates of medical illness. Psychosomatics 22: 5: 384–391.PubMedGoogle Scholar
  34. 34).
    Swett, Jr. C.: 1975. Adverse reactions to chlorpromazine in psychiatric patients: A report from the Boston Collaborative Drug Surveillance Program. Boston University Medical Center. Dis. of Nerv. Syst. 509–511.Google Scholar
  35. 35).
    Warnes, H., Fitzpatrick, C.: 1979. Oral contraceptives and depression. Psychosomatics, 20: 3: 187–194.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • L. K. Oyewumi
    • 1
    • 2
  1. 1.Department of PsychiatryUniversity of OttawaCanada
  2. 2.Specialty ClinicsThe Royal Ottawa HospitalOttawaCanada

Personalised recommendations